Abstract
Antigen tests for severe acute respiratory coronavirus 2 sometimes show positive lines earlier than their specified read time, although the implication of getting the results at earlier time is not well understood. This study aimed to evaluate the clinical utility of an antigen test by evaluating the time period to get positive results and by comparing the test sensitivity with that of a digital immunoassay (DIA) test.
We prospectively collected additional nasopharyngeal samples from patients who had already tested positive for SARS-CoV-2 by reverse transcription PCR. The additional swab was used for an antigen test, QuickNavi™-COVID19 Ag, and the time periods to get positive results were measured. The sensitivity of QuickNavi™-COVID19 Ag was also compared with that of a DIA.
In 84 of 96 (87.5%) analyzed cases, the results of QuickNavi™-COVID19 Ag were positive. The time to obtain positive results was 15.0 seconds in median (inter quartile range: 12.0-33.3, range 11-736), and was extended in samples with higher cycle thresholds (Ct) (p<0.001). Positive lines appeared within a minute in 85.7% of cases and within 5 minutes in 96.4%. The sensitivities of QuickNavi™-COVID19 Ag and the DIA were 87.5% (95% confident interval [CI]: 79.2%-93.4%) and 88.6% (95%CI: 75.4%- 96.2%), respectively. Their results were concordant in 90.9% of cases, with discrepancies present only in cases with Ct values >32.
QuickNavi™-COVID19 Ag immediately showed positive results in most cases, and the time to a positive reaction may have indicated the viral load. In addition, the sensitivity of the test was comparable to the DIA.
Competing Interest Statement
Denka Co., Ltd., and Mizuho Medy Co., Ltd. provided test kits free of charge. Regarding this study, Hiromichi Suzuki received lecture fees from Denka Co., Ltd., and Otsuka Pharmaceutical Co., Ltd., and a consultation fee from Mizuho Medy Co., Ltd. Daisuke Kato, Miwa Kuwahara, and Shino Muramatsu are employed by Denka Co., Ltd., the developer of QuickNavi™-COVID19 Ag.
Funding Statement
Denka Co., Ltd., and Mizuho Medy Co., Ltd. provided test kits free of charge. Regarding this study, Hiromichi Suzuki received lecture fees from Denka Co., Ltd., and Otsuka Pharmaceutical Co., Ltd., and a consultation fee from Mizuho Medy Co., Ltd.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of Tsukuba Medical Center Hospital (TMCH) approved the present study (approval number: 2020-033).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of each author: Yusaku Akashi, yusaku-akashi{at}umin.ac.jp; Yoshihiko Kiyasu, kiyasu-tuk{at}umin.ac.jp; Yuto Takeuchi, yuto-takeuchi{at}umin.ac.jp; Daisuke Kato, daisuke-kato{at}denka.co.jp; Miwa Kuwahara, miwa-kuwahara{at}denka.co.jp; Shino Muramatshu, shino-muramatsu{at}denka.co.jp; Atsuo Ueda, atsuo.ueda06090727{at}outlook.jp; Shigeyuki Notake, notake{at}tmch.or.jp; Koji Nakamura, koji-nakamura{at}tmch.or.jp; Hiroichi Ishikawa, hishikawa{at}tmch.or.jp; Hiromichi Suzuki, hsuzuki{at}md.tsukuba.ac.jp
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
